CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.
CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.
CareCloud, Inc. director Bill Korn reported a disposition of 10,800 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were transferred back to the issuer at $25.25 per share through a mandatory redemption, and his reported holdings of this preferred stock are now zero.
The transaction was characterized as a disposition to the issuer rather than an open market sale, indicating the redemption was driven by the security’s terms rather than an individual trading decision.
CareCloud, Inc. Chief Strategy Officer A Hadi Chaudhry reported a mandatory redemption of 7,800 shares of Series B Cumulative Redeemable Perpetual Preferred Stock at $25.25 per share. The shares were disposed of back to the issuer, and the reporting person now holds 0 shares of this security.
CareCloud, Inc. has fully redeemed and delisted its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock. On May 15, 2026, the company paid a Redemption Price of $27.52 per share, for an aggregate of approximately $41.6 million, including all accumulated and unpaid dividends.
The Series B Preferred Stock was delisted from the Nasdaq Global Market as of the close of business on May 14, 2026 following the company’s request for a Form 25 to remove it from listing and registration. All preferred holders have been paid in full, no Series B shares remain outstanding, and holders’ ongoing rights are limited to receiving the Redemption Price. The company’s common stock continues to trade on Nasdaq under the ticker “CCLD.”
CareCloud, Inc. notified the removal of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock from listing and registration on the Nasdaq Stock Market LLC. Nasdaq certified it has complied with 17 CFR 240.12d2-2 and the issuer confirmed compliance with the Exchange's voluntary withdrawal requirements.
CareCloud, Inc. notified the removal and voluntary withdrawal of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock from listing and registration on the Nasdaq Stock Market LLC. The Exchange and the issuer each certified compliance with the applicable 17 CFR 240.12d2-2 procedures for delisting and withdrawal.
CareCloud, Inc. reported first-quarter 2026 net revenue of $31.3 million, up from $27.6 million a year earlier, driven mainly by technology-enabled business solutions and recent acquisitions such as Medsphere, RevNu and MAP App. Healthcare IT contributed $27.5 million and Medical Practice Management $3.8 million of revenue.
Net income was $0.9 million versus $1.9 million in 2025 as operating expenses, including higher general and administrative and research and development costs, grew faster than revenue. After $1.4 million of preferred dividends, common shareholders recorded a $0.4 million net loss, or $(0.01) per share. Operating cash flow was $3.6 million. During the quarter, CareCloud continued integrating acquisitions, carried $31.4 million of goodwill and $16.5 million of net intangibles, and disclosed a March 2026 cybersecurity incident affecting one electronic health record environment, which is under forensic review and has prompted class action complaints from certain patients.
CareCloud, Inc. reported Q1 2026 revenue of $31.3 million, up from $27.6 million in Q1 2025, a 13% year-over-year increase. GAAP net income was $0.9 million, down from $1.9 million a year ago, while adjusted EBITDA was $5.4 million versus $5.6 million.
The company reaffirmed its full-year 2026 guidance, targeting revenue of $128–$132 million, adjusted EBITDA of $29–$31 million, and GAAP EPS of $0.20–$0.23, compared to $0.10 in 2025. Management highlighted a new $50 million credit facility, the announced full cash redemption of all Series B Preferred Stock on May 15, 2026, and AI product launches, including stratusAI Desk Agent automating roughly 75% of inbound calls.
CareCloud, Inc. intends to sell up to $60,000,000 of common stock through an At-The-Market offering under an At The Market Offering Agreement dated April 13, 2026 with Citizens JMP Securities, LLC. Sales may occur from time to time on the Nasdaq or in other permitted transaction types as an “at-the-market offering.” The placement agent fee is 3.0% of gross proceeds and Citizens will be deemed an underwriter for Securities Act purposes. Net proceeds, if any, will be used for working capital and general corporate purposes, which may include acquisitions, debt repayment, capital expenditures and redemption of preferred stock.
CareCloud, Inc. entered into a new Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility maturing on the fourth anniversary of closing. The loans are secured by substantially all company and subsidiary assets and carry interest based on SOFR or an alternate base rate plus a margin.
As part of the collateral package, Executive Chairman Mahmud Haq will pledge certain securities accounts and receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. The company also put in place an at-the-market equity program to sell up to $60 million of common stock through Citizens JMP Securities.
CareCloud elected to redeem all 1,511,372 outstanding shares of its 8.75% Series B Preferred Stock on May 15, 2026 at $25.25 per share plus $2.27 of accrued dividends, for total cash of $27.52 per share. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividends; management notes the company generates about $30 million in annualized adjusted EBITDA.
CareCloud, Inc. is asking shareholders to vote at its June 4, 2026 annual meeting on director elections, executive pay, a new 2026 Equity Incentive Plan, and ratification of Tanner LLP as auditor for 2026.
The proxy describes governance structures, board and committee activity, and detailed director and executive compensation, including 2025 salaries such as $300,000 for Executive Chairman Mahmud Haq and co-CEOs. It also outlines related-party arrangements, including leases with the Executive Chairman and consulting agreements with family members and a director-controlled entity. The new 2026 Equity Incentive Plan would authorize up to 1,000,000 shares for future equity awards alongside existing plan reserves.